Sahm ScreenerSaudi Stock Screenerفلتر الأسهم السعودية
Home / Almujtama Alraida Medical Co. / 2022 Annual Results

Almujtama Alraida Medical Co. 2022 Annual Results

Revenue
SAR 367M
Net Profit
SAR 19M
EPS
SAR 2.01
Operating Cash Flow
SAR 19M

Almujtama Alraida Medical Co. (9592) reported full year 2022 revenue of SAR 367M. Net profit came in at SAR 19M. Earnings per share were SAR 2.01. The company generated SAR 19M in operating cash flow. All figures sourced from CMA-mandated XBRL filings on the Saudi Exchange, processed by Sahm Screener.

Earnings Quality

Of every SAR 1.00 in reported net profit, SAR 0.97 arrived as operating cash flow — indicating High quality earnings with a cash conversion ratio of 0.97.

Key Financial Metrics

Metric2022
RevenueSAR 367M
Net ProfitSAR 19M
Net Margin5.2%
ROE16.1%
EPSSAR 2.01
Total AssetsSAR 334M
Total EquitySAR 119M
Total LiabilitiesSAR 216M
Operating Cash FlowSAR 19M

Financial data sourced from CMA-mandated XBRL filings published on the Saudi Exchange (Tadawul). Data processed and structured by Sahm Screener (sahmscreener.com). Updated nightly. Last updated: 2023-11-21.